A processing method for flash-steamed medical protective material without intradermal irritation reaction
By using modified functional particles in the flash evaporation spinning process, the problem of flash evaporation polyethylene material in the intradermal stimulation reaction is solved, and a flash evaporation medical protective material without intradermal stimulation reaction is achieved, with better longitudinal pulling Extension and wear resistance have expanded their application in the field of medical protection.
Patent Information
- Application Number
- CN202410987853.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-23
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2044-07-23
AI Technical Summary
The existing flash evaporated polyethylene medical protective materials have not been effectively studied in the intradermal stimulation response, which limits its wide application in the field of medical protection.
Modified functional particles are mainly composed of hydroxyapatite nanowires and sodium citrate, and are prepared by ultrasonic oscillation and drying, and are added to the spinning liquid to reduce the stimulation of the material's polarity and non-polar leaching liquid. In combination with flash evaporation spinning process, flash evaporation medical protective material without intradermal stimulation reaction was prepared.
It realizes that flash-evaporated medical protective materials have good longitudinal tensile strength and wear resistance while ensuring no intradermal stimulation reaction, which expands its application scenarios in medical protection.
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of flash-evaporated polyethylene, and in particular relates to a flash-evaporated medical protective material without intradermal irritation reaction and a processing method thereof. Background Art
[0002] Flash spinning was first proposed by scientists Herbert Blades, James Rushton White, and Chadds Ford at DuPont Research in the United States. They filed the first US patent application for flash spinning, US Patent No. 3,081,519, in 1962, and the patent was granted in March 1963. DuPont then registered the trademark "Tyvek" for the product in 1965 and officially began commercial production under the brand name in 1967. Subsequently, a large number of DuPont scientists continuously refined the process and technology over the next 30 years, ensuring DuPont's continued monopoly on this technology. Intradermal irritation is a direct indicator of the sensitivity of the skin or the intradermal area to a material. For flash-spun polyethylene to be widely used in medical protective materials, low intradermal irritation is a prerequisite, but relevant research in this area is currently lacking.
[0003] For example, a Chinese invention patent application discloses a wear-resistant flash-steamed medical protective material and a processing method thereof [application number: 202410453681.0]. The raw material of the flash-steamed medical protective material in this invention patent application contains polyethylene, and the gram weight of the flash-steamed medical protective material is greater than 35g / m; the oxygen permeability of the flash-steamed medical protective material is 1.5*10~4.5*10cm / (m*24h*0.1MPa); the wear resistance grade of the flash-steamed medical protective material is above level 5; the wear resistance test standard is Appendix J of GB 24539-2021 "Protective Clothing Chemical Protective Clothing"; J4.2 Hydrostatic Pressure Method; the oxygen permeability test standard is GB / T19789-2021 "Oxygen Permeability Test of Plastic Film and Sheet for Packaging Materials - Coulometer Detection Method".
[0004] This invention patent application has made relevant modifications to improve the wear resistance of the flash-evaporated polyethylene material, but it has not yet been tested for intradermal irritation reactions, resulting in its application in the field of medical protective materials being very limited. Summary of the Invention
[0005] The purpose of the present invention is to provide a method for processing a flash-evaporated medical protective material without intradermal irritation reaction in order to solve the above problems.
[0006] In order to achieve the above object, the present invention adopts the following technical solutions:
[0007] A flash-evaporated medical protective material having no intradermal irritation reaction, wherein the final score of the polar and non-polar extracts of the flash-evaporated medical protective material is not greater than 1.0;
[0008] The test standard for the flash steam intradermal reaction test of medical protective materials is ISO10993-23:2021, the polar extract is 0.9% sodium chloride injection, and the non-polar extract is sesame oil.
[0009] In the above-mentioned flash-evaporated medical protective material without intradermal irritation reaction, the final scores of the polar and non-polar extracts of the flash-evaporated medical protective material are no more than 0.7.
[0010] In the above-mentioned flash-evaporated medical protective material without intradermal irritation reaction, the final scores of the polar and non-polar extracts of the flash-evaporated medical protective material are no more than 0.4.
[0011] In the above-mentioned flash-evaporated medical protective material without intradermal irritation reaction, the final scores of the polar and non-polar extracts of the flash-evaporated medical protective material are no more than 0.1.
[0012] The longitudinal tensile strength of the flash-steamed medical protective material is 2.2~4KN / m.
[0013] The longitudinal tensile elongation at break of the flash-steamed medical protective material is 12-25%.
[0014] The method for processing the above-mentioned flash-evaporated medical protective material without intradermal irritation reaction comprises the following steps:
[0015] Step 1: Add the modified functional particles, spinning solvent and polyethylene into a mixing kettle at a temperature of 170-200°C and a pressure of 200-210 bar to obtain a spinning solution;
[0016] The mass fraction of polyethylene in the spinning solution is 7-12%;
[0017] Step 2: flash spinning the spinning solution obtained in step 1 at a spinning temperature of 200-220° C. to obtain flash fibers, and then laying and hot rolling the flash fibers at a hot rolling temperature of 105-115° C. to obtain flash medical protective materials;
[0018] In the above-mentioned method for processing a flash-evaporated medical protective material without intradermal irritation reaction, the added mass of the modified functional particles is 1.0 to 5.0% of the added mass of the polyethylene.
[0019] In the above-mentioned method for processing the flash-evaporated medical protective material without intradermal irritation reaction, the added mass of the modified functional particles is 1.0 to 2% of the added mass of the polyethylene.
[0020] In the above-mentioned method for processing the flash-evaporated medical protective material without intradermal irritation reaction, the added mass of the modified functional particles is 2-3% of the added mass of the polyethylene.
[0021] In the above-mentioned method for processing the flash-evaporated medical protective material without intradermal irritation reaction, the added mass of the modified functional particles is 3-4% of the added mass of the polyethylene.
[0022] In the above-mentioned method for processing the flash-evaporated medical protective material without intradermal irritation reaction, the added mass of the modified functional particles is 4-5% of the added mass of the polyethylene.
[0023] In the above-mentioned method for processing a flash-evaporated medical protective material without intradermal irritation reaction, the modified functional particles are prepared by the following method:
[0024] Step A: Prepare a sodium citrate solution with a concentration of 1 to 2 mmol / L using water as a solvent and set aside;
[0025] Step B: adding hydroxyapatite nanowires to a sodium citrate solution, ultrasonically vibrating for 30 to 60 minutes, centrifuging, discarding the supernatant, and solid-phase drying to obtain modified functional particles.
[0026] Compared with the existing technology, the advantages of the present invention are:
[0027] 1. By adding modified functional particles, the flash-steamed medical protective material prepared in the present invention not only ensures no intradermal irritation reaction but also has good longitudinal tensile strength, thereby expanding the application scenarios of the material in medical protection.
[0028] 2. The modified functional particles of the present invention use hydroxyapatite nanowires as the main material and sodium citrate as a dispersant to prevent them from agglomerating, thereby ensuring their modification effect on the strength of flash polyethylene. At the same time, compared with the method in the prior art of coupling modification of the hydroxyapatite surface to prevent agglomeration, the operation is simpler. DETAILED DESCRIPTION
[0029] The present invention will be further described in detail below with reference to specific embodiments.
[0030] Example 1
[0031] This embodiment provides a method for processing a flash-evaporated medical protective material without intradermal irritation reaction, comprising the following steps:
[0032] Step 1: Prepare a 1 mmol / L sodium citrate solution using water as solvent and set aside;
[0033] Step 2: Add hydroxyapatite nanowires to sodium citrate solution, ultrasonically vibrate for 30 minutes, centrifuge, discard the supernatant, and dry the solid phase to obtain modified functional particles;
[0034] Step 3: Adding a spinning solvent, polyethylene, and the modified functional particles prepared in step 2 into a mixing kettle at a temperature of 170° C. and a pressure of 200 bar to obtain a spinning solution. The mass of the modified functional particles added is 1.0% of the mass of the polyethylene added. The spinning solvent is obtained by mixing dichloromethane, 1,1-dichloro-2,2,2-trifluoroethane, monochlorodichloromethane, and 1H-perfluorohexane in a mass ratio of 6:2:1:1. The mass fraction of polyethylene in the spinning solution is 7%.
[0035] Step 4: The spinning solution obtained in step 3 is flash-spun at a spinning temperature of 200°C to obtain flash fibers. The flash fibers are laid and hot-rolled at a hot-rolling temperature of 105°C to obtain flash medical protective materials.
[0036] The weight of flash-steamed medical protective material is 51g / m 2 , the longitudinal tensile strength is 2.8KN / m, and the longitudinal tensile elongation at break is 24%.
[0037] The flash-evaporated medical protective material prepared in this embodiment was subjected to an intradermal reaction test according to the test standard described in ISO10993-23:2021, wherein the polar extract was 0.9% sodium chloride injection and the non-polar extract was sesame oil, and the final score of the measured polar and non-polar extracts was 0.
[0038] The hydroxyapatite nanowires used in the embodiments and comparative examples of the present invention were purchased from Beijing Beike New Materials Technology Co., Ltd. with the product number: BkZNZ2020102066-01.
[0039] Example 2
[0040] This embodiment provides a method for processing a flash-evaporated medical protective material without intradermal irritation reaction, comprising the following steps:
[0041] Step 1: Prepare a 2 mmol / L sodium citrate solution using water as solvent and set aside;
[0042] Step 2: Add hydroxyapatite nanowires to sodium citrate solution, ultrasonically vibrate for 60 minutes, centrifuge, discard the supernatant, and dry the solid phase to obtain modified functional particles;
[0043] Step 3: Adding a spinning solvent, polyethylene, and the modified functional particles prepared in step 2 into a mixing kettle at a temperature of 200° C. and a pressure of 210 bar to obtain a spinning solution. The mass of the modified functional particles added is 5.0% of the mass of the polyethylene added. The spinning solvent is obtained by mixing dichloromethane, 1,1-dichloro-2,2,2-trifluoroethane, monochlorodichloromethane, and 1H-perfluorohexane in a mass ratio of 6:2:1:1. The mass fraction of polyethylene in the spinning solution is 12%.
[0044] Step 4: The spinning solution obtained in step 3 is flash-spun at a spinning temperature of 220°C to obtain flash fibers. The flash fibers are laid and hot-rolled at a hot-rolling temperature of 115°C to obtain flash medical protective materials.
[0045] The weight of the flash-steamed medical protective material is 52g / m 2 , the longitudinal tensile strength is 3.9KN / m, and the longitudinal tensile elongation at break is 15%.
[0046] The flash-evaporated medical protective material prepared in this embodiment was subjected to an intradermal reaction test according to the test standard described in ISO10993-23:2021, wherein the polar extract was 0.9% sodium chloride injection and the non-polar extract was sesame oil, and the final score of the measured polar and non-polar extracts was 0.
[0047] Example 3
[0048] This embodiment provides a method for processing a flash-evaporated medical protective material without intradermal irritation reaction, comprising the following steps:
[0049] Step 1: Prepare a 1.5 mmol / L sodium citrate solution using water as solvent and set aside;
[0050] Step 2: Add hydroxyapatite nanowires to sodium citrate solution, ultrasonically vibrate for 45 minutes, centrifuge, discard the supernatant, and dry the solid phase to obtain modified functional particles;
[0051] Step 3: Adding a spinning solvent, polyethylene, and the modified functional particles prepared in step 2 into a mixing kettle at a temperature of 185° C. and a pressure of 205 bar to obtain a spinning solution. The mass of the modified functional particles added is 3.0% of the mass of the polyethylene added. The spinning solvent is obtained by mixing dichloromethane, 1,1-dichloro-2,2,2-trifluoroethane, monochlorodichloromethane, and 1H-perfluorohexane in a mass ratio of 6:2:1:1. The mass fraction of polyethylene in the spinning solution is 10%.
[0052] Step 4: The spinning solution obtained in step 3 is flash-spun at a spinning temperature of 210°C to obtain flash-spun fibers. The flash-spun fibers are laid and hot-rolled at a hot-rolling temperature of 110°C to obtain flash-spun medical protective materials.
[0053] The weight of the flash-steamed medical protective material is 52g / m 2 , the longitudinal tensile strength is 3.5KN / m, and the longitudinal tensile elongation at break is 21%.
[0054] The flash-evaporated medical protective material prepared in this embodiment was subjected to an intradermal reaction test according to the test standard described in ISO10993-23:2021, wherein the polar extract was 0.9% sodium chloride injection and the non-polar extract was sesame oil, and the final score of the measured polar and non-polar extracts was 0.
[0055] Comparative Example 1
[0056] This comparative example provides a method for processing a flash vaporized medical protective material, comprising the following steps:
[0057] Step 1: adding a spinning solvent and polyethylene into a mixing kettle at a temperature of 185° C. and a pressure of 205 bar to obtain a spinning solution, wherein the spinning solvent is obtained by mixing dichloromethane, 1,1-dichloro-2,2,2-trifluoroethane, monochlorodichloromethane, and 1H-perfluorohexane in a mass ratio of 6:2:1:1; the mass fraction of polyethylene in the spinning solution is 10%;
[0058] Step 2: The spinning solution obtained in step 1 is flash-spun at a spinning temperature of 210°C to obtain flash fibers. The flash fibers are laid and hot-rolled at a hot-rolling temperature of 110°C to obtain flash medical protective materials.
[0059] The weight of flash-steamed medical protective material is 51g / m 2 , the longitudinal tensile strength is 1.9KN / m, and the longitudinal tensile elongation at break is 28%.
[0060] The flash-steamed medical protective material prepared in this comparative example was subjected to an intradermal reaction test according to the test standard described in ISO10993-23:2021, wherein the polar extract was 0.9% sodium chloride injection and the non-polar extract was sesame oil, and the final score of the measured polar and non-polar extracts was 0.
[0061] Comparative Example 2
[0062] This comparative example provides a method for processing a flash vaporized medical protective material, comprising the following steps:
[0063] Step 1: Add hydroxyapatite nanowires to water, ultrasonically vibrate for 45 minutes, centrifuge, discard the supernatant, and dry the solid phase to obtain modified functional particles;
[0064] Step 2: Adding a spinning solvent, polyethylene, and the modified functional particles prepared in step 2 into a mixing kettle at a temperature of 185° C. and a pressure of 205 bar to obtain a spinning solution. The mass of the modified functional particles added is 3.0% of the mass of the polyethylene added. The spinning solvent is obtained by mixing dichloromethane, 1,1-dichloro-2,2,2-trifluoroethane, monochlorodichloromethane, and 1H-perfluorohexane in a mass ratio of 6:2:1:1. The mass fraction of polyethylene in the spinning solution is 10%.
[0065] Step 3: flash-spin the spinning solution obtained in step 1 at a spinning temperature of 210°C to obtain flash-spun fibers, lay the flash-spun fibers and perform hot rolling at a temperature of 110°C to obtain flash-spun medical protective materials.
[0066] The weight of the flash-steamed medical protective material is 52g / m 2 , the longitudinal tensile strength is 3.0KN / m, and the longitudinal tensile elongation at break is 23%.
[0067] The flash-steamed medical protective material prepared in this comparative example was subjected to an intradermal reaction test according to the test standard described in ISO10993-23:2021, wherein the polar extract was 0.9% sodium chloride injection and the non-polar extract was sesame oil, and the final score of the measured polar and non-polar extracts was 0.
[0068] Comparative Example 3
[0069] This comparative example provides a method for processing a flash vaporized medical protective material, comprising the following steps:
[0070] Step 1: Prepare a 1.5 mmol / L sodium hexametaphosphate solution using water as solvent and set aside;
[0071] Step 2: Add hydroxyapatite nanowires to sodium hexametaphosphate solution, ultrasonically vibrate for 45 minutes, centrifuge, discard the supernatant, and dry the solid phase to obtain modified functional particles;
[0072] Step 3: Adding a spinning solvent, polyethylene, and the modified functional particles prepared in step 2 into a mixing kettle at a temperature of 185° C. and a pressure of 205 bar to obtain a spinning solution. The mass of the modified functional particles added is 3.0% of the mass of the polyethylene added. The spinning solvent is obtained by mixing dichloromethane, 1,1-dichloro-2,2,2-trifluoroethane, monochlorodichloromethane, and 1H-perfluorohexane in a mass ratio of 6:2:1:1. The mass fraction of polyethylene in the spinning solution is 10%.
[0073] Step 4: The spinning solution obtained in step 3 is flash-spun at a spinning temperature of 210°C to obtain flash-spun fibers. The flash-spun fibers are laid and hot-rolled at a hot-rolling temperature of 110°C to obtain flash-spun medical protective materials.
[0074] The weight of the flash-steamed medical protective material is 52g / m 2 , the longitudinal tensile strength is 3.6KN / m, and the longitudinal tensile elongation at break is 21%.
[0075] The flash-steamed medical protective material prepared in this comparative example was subjected to an intradermal reaction test according to the test standard described in ISO10993-23:2021, wherein the polar extract was 0.9% sodium chloride injection and the non-polar extract was sesame oil, and the final score of the measured polar and non-polar extracts was 2.0.
[0076] Comparative Example 4
[0077] This comparative example provides a method for processing a flash vaporized medical protective material, comprising the following steps:
[0078] Step 1: Prepare a 1.5 mmol / L sodium polyacrylate solution using water as solvent and set aside;
[0079] Step 2: Add hydroxyapatite nanowires to sodium polyacrylate solution, ultrasonically vibrate for 45 minutes, centrifuge, discard the supernatant, and dry the solid phase to obtain modified functional particles;
[0080] Step 3: Adding a spinning solvent, polyethylene, and the modified functional particles prepared in step 2 into a mixing kettle at a temperature of 185° C. and a pressure of 205 bar to obtain a spinning solution. The mass of the modified functional particles added is 3.0% of the mass of the polyethylene added. The spinning solvent is obtained by mixing dichloromethane, 1,1-dichloro-2,2,2-trifluoroethane, monochlorodichloromethane, and 1H-perfluorohexane in a mass ratio of 6:2:1:1. The mass fraction of polyethylene in the spinning solution is 10%.
[0081] Step 4: The spinning solution obtained in step 3 is flash-spun at a spinning temperature of 210°C to obtain flash-spun fibers. The flash-spun fibers are laid and hot-rolled at a hot-rolling temperature of 110°C to obtain flash-spun medical protective materials.
[0082] The weight of the flash-steamed medical protective material is 52g / m 2 , the longitudinal tensile strength is 3.4KN / m, and the longitudinal tensile elongation at break is 20%.
[0083] The flash-steamed medical protective material prepared in this comparative example was subjected to an intradermal reaction test according to the test standard described in ISO10993-23:2021, wherein the polar extract was 0.9% sodium chloride injection and the non-polar extract was sesame oil. The final scores of the measured polar and non-polar extracts were 2.3.
[0084] Comparative Example 5
[0085] This comparative example provides a method for processing a flash vaporized medical protective material, comprising the following steps:
[0086] Step 1: Prepare a 1.5 mmol / L sodium citrate solution using water as solvent and set aside;
[0087] Step 2: Add the nano-glass fibers to the sodium citrate solution, ultrasonically vibrate for 45 minutes, centrifuge, discard the supernatant, and dry the solid phase to obtain the modified functional particles;
[0088] Step 3: Adding a spinning solvent, polyethylene, and the modified functional particles obtained in step 2 into a mixing kettle at a temperature of 185° C. and a pressure of 205 bar to obtain a spinning solution. The mass of the modified functional particles added is 3.0% of the mass of the polyethylene added. The spinning solvent is obtained by mixing dichloromethane, 1,1-dichloro-2,2,2-trifluoroethane, monochlorodichloromethane, and 1H-perfluorohexane in a mass ratio of 6:2:1:1. The mass fraction of polyethylene in the spinning solution is 10%.
[0089] Step 4: The spinning solution obtained in step 3 is flash-spun at a spinning temperature of 210°C to obtain flash-spun fibers. The flash-spun fibers are laid and hot-rolled at a hot-rolling temperature of 110°C to obtain flash-spun medical protective materials.
[0090] The weight of the flash-steamed medical protective material is 52g / m 2 , the longitudinal tensile strength is 4.7KN / m, and the longitudinal tensile elongation at break is 10%.
[0091] The flash-steamed medical protective material prepared in this comparative example was subjected to an intradermal reaction test according to the test standard described in ISO10993-23:2021, wherein the polar extract was 0.9% sodium chloride injection and the non-polar extract was sesame oil. The final score of the measured polar and non-polar extracts was 6.2.
[0092] Comparative Example 6
[0093] This comparative example provides a method for processing a flash-evaporated medical protective material without intradermal irritation reaction, comprising the following steps:
[0094] Step 1: Prepare a 1.5 mmol / L sodium citrate solution using water as solvent and set aside;
[0095] Step 2: Add hydroxyapatite powder to sodium citrate solution, ultrasonically vibrate for 45 minutes, centrifuge, discard the supernatant, and dry the solid phase to obtain modified functional particles;
[0096] Step 3: Adding a spinning solvent, polyethylene, and the modified functional particles prepared in step 2 into a mixing kettle at a temperature of 185° C. and a pressure of 205 bar to obtain a spinning solution. The mass of the modified functional particles added is 3.0% of the mass of the polyethylene added. The spinning solvent is obtained by mixing dichloromethane, 1,1-dichloro-2,2,2-trifluoroethane, monochlorodichloromethane, and 1H-perfluorohexane in a mass ratio of 6:2:1:1. The mass fraction of polyethylene in the spinning solution is 10%.
[0097] Step 4: The spinning solution obtained in step 3 is flash-spun at a spinning temperature of 210°C to obtain flash-spun fibers. The flash-spun fibers are laid and hot-rolled at a hot-rolling temperature of 110°C to obtain flash-spun medical protective materials.
[0098] The weight of the flash-steamed medical protective material is 52g / m 2 , the longitudinal tensile strength is 2.1KN / m, and the longitudinal tensile elongation at break is 26%.
[0099] The flash-evaporated medical protective material prepared in this embodiment was subjected to an intradermal reaction test according to the test standard described in ISO10993-23:2021, wherein the polar extract was 0.9% sodium chloride injection and the non-polar extract was sesame oil, and the final score of the measured polar and non-polar extracts was 0.
Claims
1. A flash-steamed medical protective material without intradermal irritation reaction, characterized in that: The final score of polar and non-polar extracts of flash-evaporated medical protective materials shall not be greater than 1.0; The test standard for the flash medical protective material intradermal reaction test is ISO10993-23:2021, the polar extract is 0.9% sodium chloride injection, and the non-polar extract is sesame oil; The flash-steamed medical protective material without intradermal irritation reaction is prepared by the following processing method: Step 1: Add the modified functional particles, spinning solvent and polyethylene into a mixing kettle at a temperature of 170-200° C. and a pressure of 200-210 bar to obtain a spinning solution; Step 2: flash spinning the spinning solution obtained in step 1 at a spinning temperature of 200 to 220° C. to obtain flash fibers, and web laying and hot rolling the flash fibers at a hot rolling temperature of 105 to 115° C. to obtain flash medical protective materials; The modified functional particles are prepared by the following method: Step A: using water as solvent, prepare a sodium citrate solution with a concentration of 1-2 mmol / L for standby use; Step B: Add hydroxyapatite nanowires to sodium citrate solution, ultrasonically vibrate for 30 to 60 minutes, centrifuge, discard the supernatant, and dry the solid phase to obtain modified functional particles.
2. The flash-evaporated medical protective material without intradermal irritation reaction as claimed in claim 1, characterized in that: The final score of polar and non-polar extracts of flash-evaporated medical protective materials shall not exceed 0.
7.
3. The flash-evaporated medical protective material without intradermal irritation reaction as claimed in claim 1, characterized in that: The final score of polar and non-polar extracts of flash-evaporated medical protective materials shall not exceed 0.
4.
4. The flash-evaporated medical protective material without intradermal irritation reaction as claimed in claim 1, characterized in that: The final score of polar and non-polar extracts of flash-evaporated medical protective materials shall not exceed 0.
1.
5. The flash-evaporated medical protective material without intradermal irritation reaction as claimed in claim 1, characterized in that: The longitudinal tensile strength of the flash-steamed medical protective material is 2.2-4KN / m.
6. The flash-evaporated medical protective material without intradermal irritation reaction as claimed in claim 1, characterized in that: The longitudinal tensile elongation at break of the flash-steamed medical protective material is 12-25%.
7. A method for preparing a flash-evaporated medical protective material without intradermal irritation reaction as claimed in claim 1, characterized in that: It includes the following steps: Step 1: Add the modified functional particles, spinning solvent and polyethylene into a mixing kettle at a temperature of 170-200° C. and a pressure of 200-210 bar to obtain a spinning solution; Step 2: flash-spin the spinning solution obtained in step 1 at a spinning temperature of 200-220°C to obtain flash-spun fibers, lay the flash-spun fibers and hot-roll them at a temperature of 105-115°C to obtain flash-spun medical protective materials.
8. The method for processing a flash-evaporated medical protective material without intradermal irritation reaction as claimed in claim 7, characterized in that: The added mass of the modified functional particles is 1.0-5.0% of the added mass of the polyethylene.
9. The method for processing a flash-evaporated medical protective material without intradermal irritation reaction as claimed in claim 8, characterized in that: The added mass of the modified functional particles is 1.0-2% of the added mass of polyethylene.
10. The method for processing a flash-evaporated medical protective material without intradermal irritation reaction as claimed in claim 8, characterized in that: The added mass of the modified functional particles is 2-3% of the added mass of polyethylene.
11. The method for processing a flash-evaporated medical protective material without intradermal irritation reaction as claimed in claim 8, characterized in that: The added mass of the modified functional particles is 3-4% of the added mass of polyethylene.
12. The method for processing a flash-evaporated medical protective material without intradermal irritation reaction as claimed in claim 8, characterized in that: The added mass of the modified functional particles is 4-5% of the added mass of the polyethylene.
13. The method for processing a flash-evaporated medical protective material without intradermal irritation reaction as claimed in claim 7, characterized in that: The mass fraction of polyethylene in the spinning solution is 7-12%.
14. The method for processing a flash-evaporated medical protective material without intradermal irritation reaction according to claim 7, characterized in that: The modified functional particles are prepared by the following method: Step A: using water as solvent, prepare a sodium citrate solution with a concentration of 1-2 mmol / L for standby use; Step B: Add hydroxyapatite nanowires to sodium citrate solution, ultrasonically vibrate for 30 to 60 minutes, centrifuge, discard the supernatant, and dry the solid phase to obtain modified functional particles.
Citation Information
Patent Citations
Wear-resistant flash medical protective material and processing method thereof
CN118048706A
Fibrillated strand
US3081519A
Hydroxyapatite / PVA (polyvinyl alcohol) fiber material and preparation method thereof
CN102828271A
Flash non-woven fabric and spinning pump thereof
CN117867672A
Method for preparing NANO fiber web comprising apatite with high antibacterial function
KR1020120095556A
